News & Events
Berkowitz Family Foundation Funds Lecture Highlighting Humanism in Medicine
First annual lecture, March 5th, brings Art Caplan, PhD, back to Philadelphia.
Takami Sato, MD, Named Endowed Professor of Medical Oncology in Honor of Distinguished Japanese Physicians
Internationally-recognized cancer clinician and researcher Takami Sato, MD, PhD, who serves as the Director of the Metastatic Uveal Melanoma Program in the Department of Medical Oncology at Thomas...
Phone and Mailed Interventions Significantly Increase Colorectal Cancer Screening Rates
Patients three times more likely to get screened with phone navigation and mailings, researchers at Jefferson's Kimmel Cancer Center found.
Improving Prostate Cancer Outcomes in Ghana Could Take More Screenings, Tailored Treatments—and Breaking Down the Stigma
Low screening rates and lack of treatment resulting in late-stage diagnoses, poor outcomes in prostate cancer patients in West African nation.
Medication Errors in the Elderly Are Costing at Least $4.2 Billion Annually: Jefferson's Proof-of-Concept Study Points to a Solution
Researchers at the Jefferson School of Population Health, working with colleagues at the Parma Local Health Authority in Italy, significantly reduced the prescribing of dangerous medications for older...
Bench to Bedside: How to Fast Track Targeted Cancer Drugs with Radiation into the Clinic
Researchers from the translational research program of the National Cancer Institute and the Radiation Therapy Oncology Therapy Group have developed new guidelines to help fast track the clinical...
Researchers at Jefferson's Kimmel Cancer Center Discover New Pathways that Drive Metastatic Prostate Cancer
Elevated levels of Cyclin D1b could function as a novel biomarker of lethal metastatic disease in prostate cancer patients, according to a pre-clinical study published ahead of print on December...
Game Changing Diagnostic and Prognostic Prostate Cancer Genetic Tests Revealed by Jefferson's Kimmel Cancer Center
Researchers at the Kimmel Cancer Center at Jefferson (KCC) have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes...
Promising Drug Slows Down Advance of Parkinson's Disease and Improves Symptoms
GM1 ganglioside slowed progression of disease in patients over at least a two-year period.
Thomas Jefferson University Honoring Cancer Pioneer Axel Ullrich with Lennox K. Black International Prize
Two-day symposium Nov. 29 and 30 will focus on individualized medicine.